SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) and Astellas Pharma Inc. Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Genitourinary Cancers Symposium